MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd)

Drug Alert Number: EL(26)A/07

Date issued: 04 February 2026

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.

DMRC reference number: DMRC – 38319360

Marketing Authorisation Holder: Aspar Pharmaceuticals Ltd

Medicine Details

  • Ibuprofen 200 mg Tablets
  • Ibucalm 200 mg Tablets

PL: 08977/0016

Active ingredient: Ibuprofen

SNOMED code: N/A

GTIN: 5010441006481 (Numark), 5060057401989 (Almus), 5024071270358 (Ibucalm)

Affected Lot Batch Numbers:

Batch No. Expiry Date Pack Size First Distributed
250135 Almus 31/12/2026 24 18/06/2025
250399 Almus 30/06/2027 24 04/08/2025
250125 Numark 31/12/2026 24 27/05/2025
250109 Aspar 31/12/2026 48 25/03/2025

Background

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. The investigation confirmed that other batches were not impacted since the issue is related to a specific batch of aluminium foil utilised for these four batches of tablets. These products are Pharmacy (P) medicines and can only be sold or dispensed from a registered pharmacy premises by a pharmacist, or by staff acting under their direct supervision.

Advice for healthcare professionals

Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

View full alert here.

Advice for Healthcare Professionals to Provide to Patients

No further action is required by patients as this recall is being undertaken at a Pharmacy and Wholesaler level as a precautionary measure. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Additional Information

For all enquiries regarding this product, please call 020 8205 9846 extension 2209 or email adrian.zahra@aspar.co.uk.

The post MHRA Class 3 Medicines Recall: Ibuprofen 200mg Tablets, Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) appeared first on Community Pharmacy England.